Skip to main content
. 2019 Jul 4;10:2961. doi: 10.1038/s41467-019-10766-0

Fig. 6.

Fig. 6

FHR1 binds to MDA-LDL on necrotic cells. a FHR1 binds to MDA-LDL, but not to LDL or BSA. b FHR1 binds to MDA-LDL in a dose-dependent manner as shown by ELISA and c surface plasmon resonance. d FHR1 binds to MDA epitopes on necrotic cells, as demonstrated by proximity ligation assay. Red dots denote FHR1-MDA complexes. DNA is stained with DAPI (blue). Control = one antibody. e FHR1 binds with its N-terminus FHR1 SCR1-2 to MDA-LDL. f FHR1 bound to MDA-LDL, but not LDL, increases IL-1β release by monocytes. Data in af represent the mean ± SEM. of three to four independent experiments with different cell donors. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 (unpaired two-tailed t-test)